Role of the advanced nurse practitioner within the vascular team: A qualitative study of vascular physicians and nurses.

advanced nurse practitioner advanced practice cardiovascular prevention healthcare circuit nursing peripheral artery disease vascular medicine

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 14 10 2022
accepted: 07 03 2023
medline: 18 4 2023
entrez: 17 4 2023
pubmed: 18 4 2023
Statut: epublish

Résumé

To assess the perception of Advanced Nurse Practitioners (ANP) by physicians and nurses in vascular medicine. As the status of ANP in France was recently enacted by law in 2018, we aimed to investigate physicians and nurses working with patients suffering from Peripheral Artery Disease (PAD) to gather their opinions and draw the cooperation outlines these practitioners could have with an ANP. A qualitative study based on in-depth interviews was conducted among healthcare practitioners taking care of patients with PAD: 10 physicians working either in a private practice settings or hospital settings or both, and eight nurses working within a hospital inpatients vascular unit. Verbatim responses were extracted and coded according to a continuous thematization method. Three main features emerged from participants' responses. Vascular medicine has a specific organization with a significant lack of time and staff to fulfill the mission regarding patients' severity of illness. Second, the ANP is wanted to fill part of this gap. The expected benefits include a smoother care pathway and increased capacity for cardiovascular education and prevention, especially during consultations. Lastly, some clarification is required to integrate such new practitioners within vascular teams already in place. Advanced nurse practitioners could be the missing link in a "Vascular team" by creating a continuum in the care of patients with PAD, ensuring clinical assessment, nursing supervision, adverse event screening, and renewing drug prescriptions with the required adaptations while ensuring essential part of therapeutic education adapted to each patient.

Identifiants

pubmed: 37064660
doi: 10.3389/fpubh.2023.1070403
pmc: PMC10098095
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1070403

Informations de copyright

Copyright © 2023 Kubiak, Sitruk, Durivage, Khider, Mohamedi, Détriché, Messas, Mirault and Goudot.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Am Coll Cardiol. 2017 May 9;69(18):2301-2303
pubmed: 28473135
Evid Based Nurs. 2018 Jul;21(3):63-64
pubmed: 29858278
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Fam Med Community Health. 2019 Mar 8;7(2):e000057
pubmed: 32148704
Int J Nurs Stud. 2021 Apr;116:103723
pubmed: 32826079
Ir Med J. 2015 Jul-Aug;108(7):204-7
pubmed: 26349349
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
J Vasc Nurs. 2013 Mar;31(1):2-8
pubmed: 23481875
Circ Res. 2015 Apr 24;116(9):1509-26
pubmed: 25908725
Clin Interv Aging. 2015 Jul 10;10:1147-53
pubmed: 26203234
Front Cardiovasc Med. 2021 Nov 22;8:777016
pubmed: 34881314
Lancet. 2018 Jan 20;391(10117):219-229
pubmed: 29132880
Clin Cardiol. 2018 Jun;41(6):817-824
pubmed: 29667200
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Ann Vasc Surg. 2020 Oct;68:522-526
pubmed: 32479881
J Am Coll Cardiol. 2017 May 9;69(18):2293-2300
pubmed: 28473134
Atherosclerosis. 2010 Dec;213(2):598-603
pubmed: 20947087
Sante Publique. 2017 Apr 27;29(2):241-254
pubmed: 28737343
BMC Fam Pract. 2013 Mar 18;14:36
pubmed: 23506390
Eur J Prev Cardiol. 2012 Jun;19(3):541-50
pubmed: 21502280
Circulation. 2021 Aug 31;144(9):e171-e191
pubmed: 34315230

Auteurs

Thibaut Kubiak (T)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Jonas Sitruk (J)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Andréanne Durivage (A)

Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC, Canada.

Lina Khider (L)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Nassim Mohamedi (N)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Grégoire Détriché (G)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Emmanuel Messas (E)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Tristan Mirault (T)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Guillaume Goudot (G)

Vascular Medicine Department, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH